Disc Medicine Stock Buy Hold or Sell Recommendation
| IRON Stock | 64.55 1.90 3.03% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Disc Medicine is 'Strong Sell'. The recommendation algorithm takes into account all of Disc Medicine's available fundamental, technical, and predictive indicators you will find on this site.
Check out Disc Medicine Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide. In addition, we conduct extensive research on individual companies such as Disc and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Disc |
Execute Disc Medicine Buy or Sell Advice
The Disc recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Disc Medicine. Macroaxis does not own or have any residual interests in Disc Medicine or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Disc Medicine's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Disc Medicine Trading Alerts and Improvement Suggestions
| Disc Medicine appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (76.43 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Disc Medicine generates negative cash flow from operations | |
| Over 98.0% of the company shares are owned by institutional investors |
Disc Medicine Returns Distribution Density
The distribution of Disc Medicine's historical returns is an attempt to chart the uncertainty of Disc Medicine's future price movements. The chart of the probability distribution of Disc Medicine daily returns describes the distribution of returns around its average expected value. We use Disc Medicine price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Disc Medicine returns is essential to provide solid investment advice for Disc Medicine.
| Mean Return | 0.50 | Value At Risk | -4.25 | Potential Upside | 5.21 | Standard Deviation | 4.22 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Disc Medicine historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Disc Medicine Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Disc Medicine or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Disc Medicine's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Disc stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.53 | |
β | Beta against Dow Jones | -0.34 | |
σ | Overall volatility | 4.22 | |
Ir | Information ratio | 0.09 |
Disc Medicine Volatility Alert
Disc Medicine currently demonstrates below-average downside deviation. It has Information Ratio of 0.09 and Jensen Alpha of 0.53. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Disc Medicine's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Disc Medicine's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Disc Medicine Fundamentals Vs Peers
Comparing Disc Medicine's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Disc Medicine's direct or indirect competition across all of the common fundamentals between Disc Medicine and the related equities. This way, we can detect undervalued stocks with similar characteristics as Disc Medicine or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Disc Medicine's fundamental indicators could also be used in its relative valuation, which is a method of valuing Disc Medicine by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Disc Medicine to competition |
| Fundamentals | Disc Medicine | Peer Average |
| Return On Equity | -0.25 | -0.31 |
| Return On Asset | -0.18 | -0.14 |
| Current Valuation | 1.44 B | 16.62 B |
| Shares Outstanding | 29.76 M | 571.82 M |
| Shares Owned By Insiders | 12.47 % | 10.09 % |
| Shares Owned By Institutions | 97.73 % | 39.21 % |
| Number Of Shares Shorted | 1.64 M | 4.71 M |
| Price To Book | 4.10 X | 9.51 X |
| EBITDA | (91.03 M) | 3.9 B |
| Net Income | (76.43 M) | 570.98 M |
| Total Debt | 2.1 M | 5.32 B |
| Book Value Per Share | 15.73 X | 1.93 K |
| Cash Flow From Operations | (73.46 M) | 971.22 M |
| Short Ratio | 3.92 X | 4.00 X |
| Earnings Per Share | (3.95) X | 3.12 X |
| Target Price | 92.75 | |
| Number Of Employees | 82 | 18.84 K |
| Market Capitalization | 1.92 B | 19.03 B |
| Total Asset | 368 M | 29.47 B |
| Retained Earnings | (188.65 M) | 9.33 B |
| Working Capital | 344.22 M | 1.48 B |
| Net Asset | 368 M |
Note: Disposition of 5263 shares by Savage William Jacob of Disc Medicine at 9.86 subject to Rule 16b-3 [view details]
Disc Medicine Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Disc . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Disc Medicine Buy or Sell Advice
When is the right time to buy or sell Disc Medicine? Buying financial instruments such as Disc Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Disc Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recreation Thematic Idea Now
Recreation
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Recreation theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Disc Medicine Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Disc Medicine. If investors know Disc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Disc Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Disc Medicine is measured differently than its book value, which is the value of Disc that is recorded on the company's balance sheet. Investors also form their own opinion of Disc Medicine's value that differs from its market value or its book value, called intrinsic value, which is Disc Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Disc Medicine's market value can be influenced by many factors that don't directly affect Disc Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Disc Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.